Annual report pursuant to Section 13 and 15(d)

Statement of Stockholders' Deficit

v3.20.1
Statement of Stockholders' Deficit - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 55 $ 64,437 $ 15,862,980 $ (19,811,052) $ (3,883,580)
Balance, shares at Dec. 31, 2017 55,000 64,437,836      
Stock based compensation 175,076 175,076
Issuance of common stock in acquisition of CureDM Group Holdings LLC $ 25,000 1,225,000 1,250,000
Issuance of common stock in acquisition of CureDM Group Holdings LLC (in shares) 25,000,000      
Issuance of Series A Preferred Stock for cash $ 28 274,972 275,000
Issuance of Series A Preferred Stock for cash, shares 27,500      
Conversion of convertible note payable and accrued interest into common stock $ 17,027 1,260,039 1,277,066
Conversion of convertible note payable and accrued interest into common stock (in shares) 17,027,544      
Issuance of warrants to purchase capital stock in exchange for extension of note payable 21,121 21,121
Issuance of common stock in exchange for consulting services $ 3,667 326,333 330,000
Issuance of common stock in exchange for consulting services (in shares) 3,666,666      
Reclassification of derivative liability 10,617 10,617
Net loss       (3,601,217) (3,601,217)
Balance at Dec. 31, 2018 $ 83 $ 110,131 19,156,138 (23,412,269) (4,145,917)
Balance, shares at Dec. 31, 2018 82,500 110,131,373      
Stock based compensation 144,826 144,826
Issuance of common stock in exchange for consulting services $ 1,000 21,900 22,900
Issuance of common stock in exchange for consulting services (in shares) 1,000,000      
Net loss (3,694,079) (3,694,079)
Balance at Dec. 31, 2019 $ 83 $ 111,131 $ 19,322,864 $ (27,106,348) $ (7,672,270)
Balance, shares at Dec. 31, 2019 82,500 111,131,373